BALYASNY ASSET MANAGEMENT L.P. - 30 Jun 2025 SCHEDULE 13G Report for Lexeo Therapeutics, Inc. Common Stock, par value $0.0001 per share (LXEO)

Filing Manager: BALYASNY ASSET MANAGEMENT L.P.
Reporting Manager: Balyasny Asset Management L.P.
Security: Lexeo Therapeutics, Inc. Common Stock, par value $0.0001 per share
Symbol: LXEO
Shares outstanding: 83,540,050 shares
Disclosed Ownership: 8,345,651 shares
Ownership: 10%
Form type: SCHEDULE 13G
Filing time: 14 Aug 2025, 06:40:39 UTC
Date of event: 30 Jun 2025
Next filing: 14 Nov 2025
SEC: View on sec.gov

Reporting Managers (5)

Name	Ownership	Shares Owned	sole voting power	Signature	Title
Balyasny Asset Management L.P.	10%	8,345,651	8,345,651	/s/ Scott Schroeder	Scott Schroeder / Authorized Signatory
BAM GP LLC	10%	8,345,651	8,345,651	/s/ Scott Schroeder	Scott Schroeder / Authorized Signatory
Balyasny Asset Management Holdings LP	10%	8,345,651	8,345,651	/s/ Scott Schroeder	Scott Schroeder / Authorized Signatory
Dames GP LLC	10%	8,345,651	8,345,651	/s/ Scott Schroeder	Scott Schroeder / Authorized Signatory
Dmitry Balyasny	10%	8,345,651	8,345,651	/s/ Dmitry Balyasny	Dmitry Balyasny / Self